CompaniesRanked

2874 companies · fiscal year 2025 · SEC EDGAR · September 25, 2026

Largest healthcare companies by total assets — page 3

Ranks 201–300 of 321 · Fiscal year 2025 · Data as of September 25, 2026

Total assets
#CompanyTotal assetsYoY15-year trend
201Ascend WellnessAAWHUS$908M+0.8%
202Inspire Medical SystemsINSPUS$907M+12.2%
203GlaukosGKOSUS$893M−8.3%
204ArtivionAORTUS$885M+12.1%
205Tandem Diabetes CareTNDMUS$881M−8.9%
206XencorXNCRUS$875M−8.0%
207Orthofix MedicalOFIXUS$851M−4.8%
208Sonida Senior LivingSNDAUS$845M+0.3%
209Mirum PharmaceuticalsMIRMUS$843M+25.7%
210Corcept TherapeuticsCORTUS$837M−0.5%
211CormedixCRMDUS$826M+595.1%
212Vireo GrowthVREOFUS$817M+193.0%
213Canopy GrowthCGCCA$808M−0.2%
214NovocureNVCR$804M−35.2%
215Porch GroupPRCHUS$797M−2.0%
216Healthcare ServicesHCSGUS$794M−1.1%
217MannkindMNKDUS$792M+101.1%
218Alphatec HoldingsATECUS$791M+2.0%
219Maravai LifesciencesMRVIUS$771M−23.6%
220Cadre HoldingsCDREUS$770M+18.0%
221InmodeINMDIL$766M−2.4%
222CryoportCYRXUS$765M+8.7%
223Kiniksa Pharmaceuticals InternationalKNSAGB$764M+31.5%
224Aurinia PharmaceuticalsAUPHCA$752M+36.5%
225Usana Health SciencesUSNAUS$743M−0.7%
226ProgynyPGNYUS$742M+22.3%
227InotivNOTVQUS$734M−5.0%
228SchrodingerSDGRUS$726M−11.8%
229Warby ParkerWRBYUS$721M+6.6%
230ArvinasARVNUS$718M−34.2%
231Myriad GeneticsMYGNUS$707M−31.2%
232Axsome TherapeuticsAXSMUS$690M+21.3%
233BioventusBVSUS$684M−6.1%
234AmarinAMRNIE$671M−2.1%
235P3 Health PartnersPIIIUS$657M−16.2%
236Ufp TechnologiesUFPTUS$655M+4.1%
237AtricureATRCUS$654M+7.4%
238Twist BioscienceTWSTUS$638M+4.8%
239BilliontooneBLLNUS$633M+109.4%
240Adma BiologicsADMAUS$624M+27.7%
241Lemaitre VascularLMATUS$616M+11.6%
242Travere TherapeuticsTVTXUS$605M+1.9%
243Organogenesis HoldingsORGOUS$599M+20.3%
244Castle BiosciencesCSTLUS$579M+8.9%
245Tarsus PharmaceuticalsTARSUS$562M+49.1%
246Clover Health InvestmentsCLOVUS$541M−6.8%
247Syndax PharmaceuticalsSNDXUS$530M−26.9%
248Innovage HoldingINNVUS$527M+0.5%
249Genedx HoldingsWGSUS$524M+24.9%
250Biocryst PharmaceuticalsBCRXUS$514M+4.8%
251Rigel PharmaceuticalsRIGLUS$514M+213.2%
252Adaptive BiotechnologiesADPTUS$513M−4.9%
253OrthopediatricsKIDSUS$509M+7.5%
254Procept BioroboticsPRCTUS$508M−4.9%
255ArdelyxARDXUS$502M+15.1%
256Pharming GroupPHARNL$500M+25.0%
257Skinhealth SystemsSKINUS$500M−27.1%
258Vanda PharmaceuticalsVNDAUS$489M−25.5%
259VericelVCELUS$488M+12.8%
260Rhythm PharmaceuticalsRYTMUS$480M+22.4%
261ValnevaVALNFR$469M−9.8%
262RegenxbioRGNXUS$453M−2.8%
263Staar SurgicalSTAAUS$452M−11.4%
264Monte Rosa TherapeuticsGLUEUS$449M+2.3%
265AccurayARAYUS$448M−6.3%
266Arcutis BiotherapeuticsARQTUS$433M+24.1%
267Jushi HoldingsJUSHUS$422M−4.1%
268Stoke TherapeuticsSTOKUS$418M+54.1%
269CaredxCDNAUS$413M−15.8%
270Guardian Pharmacy ServicesGRDNUS$413M+28.6%
271HarrowHROWUS$399M+2.7%
272Ironwood PharmaceuticalsIRWDUS$397M+13.1%
273Xeris BiopharmaXERSUS$384M+18.7%
274SBC Medical GroupSBCUS$380M+43.0%
275KamadaKMDAIL$379M+1.7%
276Akebia TherapeuticsAKBAUS$377M+70.6%
277AnaptysbioANABUS$364M−24.7%
278HeartflowHTFLUS$359M+202.8%
279Establishment LabsESTAVG$357M+3.0%
280Mimedx GroupMDXGUS$343M+29.8%
281Keros TherapeuticsKROSUS$338M−45.1%
282LiquidiaLQDAUS$328M+42.4%
283Strata Critical MedicalSRTAUS$325M+26.8%
284Glass House BrandsGLASUS$319M+2.6%
285111YICN$315M−17.6%
286RxsightRXSTUS$312M−2.1%
287Omada HealthOMDAUS$305M+102.4%
288InogenINGNUS$299M+0.8%
289Tactile Systems TechnologyTCMDUS$274M−8.0%
290AngiodynamicsANGOUS$270M−7.5%
291Natures Sunshine ProductsNATRUS$261M+8.4%
292Phathom PharmaceuticalsPHATUS$259M−31.5%
293MacrogenicsMGNXUS$257M−1.8%
294Heron TherapeuticsHRTXUS$256M+9.7%
295Si-BoneSIBNUS$239M+3.5%
296EvolusEOLSUS$226M−2.9%
297CerusCERSUS$222M+10.4%
298AxogenAXGNUS$222M+8.8%
299DocgoDCGOUS$217M−52.4%
300Puma BiotechnologyPBYIUS$216M+1.4%

All figures from SEC filings · FY2025 · 100

see sources

Download this data as a CSV →

Largest companies by total assets →

By sector

By country